White Papers

1. Designing More Precise Clinical Trials Using AI-Driven Analytics 10/20/2025

   Clinical trials face staggering failure rates and inefficiencies. Discover how AI and real-world evidence streamline patient recruitment and trial design to help reshape the future of clinical research.

2. Streamlining Patient Recruitment With AI–Driven Site Identification 10/20/2025

   This study highlights the use of an RWD-driven, AI-enabled recruitment models as a transformative strategy for clinical development in hard-to-recruit populations.

3. Streamlining Clinical Trial Start-Up In Australia 10/20/2025

   Gain a comprehensive overview of how sponsors can accelerate clinical trial start-up in Australia, leveraging the nation’s unique strengths as a global hub for clinical research.

4. The Case For A New Paradigm In Geographic Atrophy Clinical Trials 10/15/2025

   Here, the author introduces a new framework for GA clinical development that integrates genetic profiling, novel biomarkers, and predictive analytics to improve precision, streamline design, and accelerate development.

5. Rethinking Clinical Operations: A Smarter, Faster Playbook For Trial Success 10/15/2025

   The CRO-sponsor partnership is now strategic, addressing communication gaps and fragmented systems to improve efficiency. Joint governance, real-time tracking, and unified technology accelerate complex trial execution.

6. Conducting Early Phase Clinical Trials In Diverse Healthy Populations 10/14/2025

   Download our guide to learn proven strategies for designing early phase clinical trials that successfully enroll diverse populations and meet FDA diversity guidance.

7. Global Vaccine Clinical Trials: Australia's Strategic Advantage 10/14/2025

   This report analyses emerging trends, regional opportunities, and Australia’s distinctive strengths in vaccine research and development.

8. Eliminate Clinical Trial White Space With The Right AI Strategy 10/9/2025

   Learn how sponsors and CROs are using agentic AI to eliminate the unproductive time caused by manual, sequential processes and fragmented data systems.

9. Gene Therapies For Rare Diseases: Advances In Platforms, Modalities, And Delivery Systems 10/6/2025

   Examine the treatment landscape for rare diseases and the rapid evolution of gene therapy across three key dimensions: editing platforms, delivery modalities, and delivery vehicles.

10. Navigating Adverse Immunostimulation: A Practical Guide For Clinical Researchers 9/30/2025

    Explore a systematic approach to evaluate adverse immunostimulation (AIS) in drug development through standardized biomarker sampling and tailored management strategies.